<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Editorial on Tristan Berchoux</title>
    <link>/tags/editorial/</link>
    <description>Recent content in Editorial on Tristan Berchoux</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>&amp;copy; 2019 by Tristan Berchoux</copyright>
    <lastBuildDate>Mon, 12 Dec 2011 23:02:40 +0000</lastBuildDate>
    
	<atom:link href="/tags/editorial/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>The Supreme Court&#39;s interpretation of statistical correlation may determine the future of personalized medicine</title>
      <link>/2011/12/12/the-supreme-courts-interpretation-of-statistical/</link>
      <pubDate>Mon, 12 Dec 2011 23:02:40 +0000</pubDate>
      
      <guid>/2011/12/12/the-supreme-courts-interpretation-of-statistical/</guid>
      <description>Summary/Background
The Supreme Court heard oral arguments last week in the case Mayo Collaborative Services vs. Prometheus Laboratories (No 10-1150). At issue is a patent Prometheus Laboratories holds for making decisions about the treatment of disease on the basis of a measurement of a specific, naturally occurring molecule and a corresponding calculation. The specific language at issue is a little technical, but the key claim from the patent under dispute is:</description>
    </item>
    
  </channel>
</rss>